FDA announces recall of certain sterile ophthalmologic preparations

MedPage Today (5/26, Petrochko) reported that the Food and Drug Administration "has announced a. recall of all sterile ophthalmologic preparations shipped from Franck's Compounding Lab since November 2011 because of the possibility of a fungal eye infection following use. The recall, originally initiated on March 19, 2012, first applied only to Brilliant Blue G, an ophthalmologic dye manufactured by the lab for use during surgical procedures." Since then, "the recall has been expanded to include all preparations labeled sterile from the company following 33 cases of fungal eye infection in seven states after administration of Brilliant Blue G or products that contain triamcinolone from the compounding lab." An investigation by the Centers for Disease Control and Prevention in conjunction with the FDA is ongoing.